ストックスクリーナーアプリを入手
7.51
7.35%
-0.65
前日終値:
$8.16
開ける：
$6.45
24時間の取引高:
276.34K
Relative Volume:
2.38
時価総額：
$88.52M
収益：
$52.29M
当期純損益:
$-73.52M
株価収益率:
-11.38
EPS:
-0.66
ネットキャッシュフロー:
$-100.45M
1週間 パフォーマンス:
+5.29%
1か月 パフォーマンス:
+38.97%
6か月 パフォーマンス:
+31.48%
1年 パフォーマンス:
-16.19%
1日の値動き範囲:
$6.18
$7.74
1週間の範囲:
$6.18
$8.82
52週間の値動き範囲:
$3.61
$8.9545
Precision Biosciences Inc Stock (DTIL) Company Profile
名前
Precision Biosciences Inc
セクター
電話
919-314-5512
住所
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
7.51 | 96.18M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.37 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.51 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.32 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 開始されました | Guggenheim | Buy |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-06-09 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 再開されました | BTIG Research | Buy |
| 2020-04-03 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-05 | 開始されました | Stifel | Buy |
| 2020-02-25 | 開始されました | William Blair | Outperform |
| 2019-08-09 | 開始されました | BTIG Research | Buy |
| 2019-07-16 | 開始されました | H.C. Wainwright | Buy |
| 2019-04-22 | 開始されました | Barclays | Overweight |
| 2019-04-22 | 開始されました | Goldman | Buy |
| 2019-04-22 | 開始されました | JP Morgan | Overweight |
| 2019-04-22 | 開始されました | Jefferies | Buy |
すべてを表示
Precision Biosciences Inc (DTIL) 最新ニュース
Precision BioSciences: Q3 Earnings Snapshot - CTPost
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Is Precision BioSciences Inc. stock a defensive play in 20252025 Support & Resistance & High Yield Stock Recommendations - newser.com
Multi asset correlation models including Precision BioSciences Inc.2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - TradingView
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
How Precision BioSciences Inc. stock trades during market volatilityQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Has Precision BioSciences Inc. found a price floorJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - TipRanks
Can Precision BioSciences Inc. stock resist market sell offsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryDollar Strength & Entry and Exit Point Strategies - newser.com
Imugene to Issue 19.5 Million Shares, Pay $3 Million in Cash to Precision Biosciences as Milestone Payment Under Licensing Agreement - MarketScreener
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidate2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Imugene to explore discussions with FDA, triggering Precision BioSciences milestone - Proactive financial news
Real time breakdown of Precision BioSciences Inc. stock performanceMarket Performance Report & Reliable Breakout Forecasts - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Will Precision BioSciences Inc. outperform the marketVolume Spike & Community Trade Idea Sharing - newser.com
Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance
A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st
Is Precision BioSciences Inc. stock positioned well for digital economyQuarterly Profit Summary & Verified Entry Point Signals - newser.com
Earnings visualization tools for Precision BioSciences Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Update & AI Driven Stock Reports - newser.com
Precision BioSciences, Inc. (DTIL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Precision BioSciences, Inc. (DTIL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Precision Biosciences Inc (DTIL) 財務データ
収益
当期純利益
現金流量
EPS
Precision Biosciences Inc (DTIL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Brown Melinda | Director |
Sep 22 '25 |
Buy |
4.89 |
1,400 |
6,846 |
21,965 |
| Kelly John Alexander | Chief Financial Officer |
Jul 03 '25 |
Sale |
4.26 |
14,827 |
63,163 |
73,485 |
0.29%
0.16%
大文字化:
|
ボリューム (24 時間):